Use of Pyrosequencing to Detect Clinically Relevant Polymorphisms in Dihydropyrimidine Dehydrogenase

This publication has 19 references indexed in Scilit:

• Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
  New England Journal of Medicine, 2003
• Cancer genomics
  Cancer Cell, 2002
• UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
  The Pharmacogenomics Journal, 2002
• Single-nucleotide polymorphisms in the public domain: how useful are they?
  Nature Genetics, 2001
• A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
  Nature, 2001
• A general approach to single-nucleotide polymorphism discovery
  Nature Genetics, 1999
• The essence of SNPs
  Gene, 1999
• Thiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine
  Annals of Internal Medicine, 1998
• Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects
  British Journal of Clinical Pharmacology, 1998
• Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism
  Clinical Pharmacology & Therapeutics, 1989